Prosthetic Aortic Valves: Challenges and Solutions
- PMID: 29868612
- PMCID: PMC5961329
- DOI: 10.3389/fcvm.2018.00046
Prosthetic Aortic Valves: Challenges and Solutions
Abstract
Aortic Valve Disease (AVD) is the most common Valvular Heart Disease (VHD), affecting millions of people worldwide. Severe AVD is treated in most cases with prosthetic aortic valve replacement, which involves the substitution of the native aortic valve with a prosthetic one. In this review we will discuss the different types of prosthetic aortic valves available for implantation and the challenges faced by patients, medical doctors, researchers and manufacturers, as well as the approaches that are taken to overcome them.
Keywords: aortic valve replacement; bioprosthesis; complications; mechanical valve; percutaneous; surgical.
Similar articles
-
[The best of valvular heart disease in 2006].Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Arch Mal Coeur Vaiss. 2007. PMID: 17405561 Review. French.
-
[Long-term follow-up of aortic or mitral valve replacement. Comparison of results following implantation of a mechanical or biological artificial valve].Herz. 1986 Apr;11(2):97-115. Herz. 1986. PMID: 3699678 German.
-
Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology.Expert Rev Med Devices. 2006 Jul;3(4):453-62. doi: 10.1586/17434440.3.4.453. Expert Rev Med Devices. 2006. PMID: 16866642 Review.
-
A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease.N Engl J Med. 1993 May 6;328(18):1289-96. doi: 10.1056/NEJM199305063281801. N Engl J Med. 1993. PMID: 8469251 Clinical Trial.
-
Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study.J Thorac Cardiovasc Surg. 2002 Mar;123(3):550-6. doi: 10.1067/mtc.2002.120337. J Thorac Cardiovasc Surg. 2002. PMID: 11882830
Cited by
-
Long-Term Stability and Biocompatibility of Pericardial Bioprosthetic Heart Valves.Front Cardiovasc Med. 2021 Sep 13;8:728577. doi: 10.3389/fcvm.2021.728577. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34589529 Free PMC article. Review.
-
Glutaraldehyde and 2,3-butanediol treatment of bovine pericardium for aortic valve bioprosthesis in sheep: a preliminary study.Ann Transl Med. 2020 Dec;8(24):1668. doi: 10.21037/atm-20-7803. Ann Transl Med. 2020. PMID: 33490180 Free PMC article.
-
Interdisciplinary Methods for Zoonotic Tissue Acellularization for Natural Heart Valve Substitute of Biomimetic Materials.Materials (Basel). 2022 Apr 1;15(7):2594. doi: 10.3390/ma15072594. Materials (Basel). 2022. PMID: 35407927 Free PMC article.
-
In vitro model assesses the susceptibility of polymeric scaffolds for material-driven heart valve regeneration to calcification.In Vitro Model. 2025 Jul 15;4(2):157-175. doi: 10.1007/s44164-025-00090-x. eCollection 2025 Aug. In Vitro Model. 2025. PMID: 40708815 Free PMC article.
-
Durability of bioprosthetic aortic valves in patients under the age of 60 years - rationale and design of the international INDURE registry.J Cardiothorac Surg. 2020 May 27;15(1):119. doi: 10.1186/s13019-020-01155-6. J Cardiothorac Surg. 2020. PMID: 32460798 Free PMC article.
References
-
- Baumgartner H, Falk V, Bax JJ, de Bonis M, Hamm C, Holm PJ. Valvular heart disease Supplement to 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J (2017) 38(36):2739–91. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources